We serve Chemical Name:Sodium 2,3,4-trifluorobenzoate CAS:402955-41-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:Sodium 2,3,4-trifluorobenzoate
CAS.NO:402955-41-3
Synonyms:Sodium 2,3,4-trifluorobenzoate;sodium 2,3,4-tris(fluoranyl)benzoate;Benzoic acid, 2,3,4-trifluoro-, sodium salt (1:1)
Molecular Formula:C7H2F3NaO2
Molecular Weight:198.075
HS Code:2916399090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:40.13000
Exact Mass:197.990463
LogP:0.46740
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like Sodium 2,3,4-trifluorobenzoate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Benzoic acid, 2,3,4-trifluoro-, sodium salt (1:1) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,sodium 2,3,4-tris(fluoranyl)benzoate Use and application,sodium 2,3,4-tris(fluoranyl)benzoate technical grade,usp/ep/jp grade.
Related News: Biogen’s Alzheimer’s drug, Aduhelm, generated $2 million in revenue in the first few weeks of its approval, the company said Thursday in releasing its second-quarter earnings along with an open letter about the controversial drug. 3,4-di-O-benzyl-6-O-levulinoyl-[13C6]-D-arabino-hex-1-enitol manufacturers “Partnering with a CDMO that has the skills and capabilities to execute a successful tech transfer is critical, as this complex, multi-step process helps lay the foundation for the new drug’s journey through to commercialization. (2-((3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)amino)phenyl)(phenyl)methanone hydrochloride suppliers Patients having Zynteglo treatment for beta thalassaemia also need conditioning treatment to clear out their bone marrow cells before receiving Zynteglo. Healthcare professionals should therefore explicitly inform patients receiving Zynteglo of the increased risk of blood cancers from medicines used in conditioning treatments. 4-hydrazino-5,6-dimethyl-pyrimidin-2-ylamine vendor & factory The business, home to popular brands such as arthritis gel Voltaren and vitamins line Centrum, generated over £10 billion in sales during 2020.,“The approval of Verquvo in the EU will provide doctors, health care professionals and patients with an important treatment option to complement currently available heart failure therapies,” he added.
